Yakira Capital Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Yakira Capital Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-54,371	Closed	-$1.1M	–	434
2022 Q4	$1.1M	Buy	+54,371	New	+$833K	0.22%	117

Yakira Capital Management's OPNT Position: Q1 2023 in Review

Yakira Capital Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q1 2023, closing a stake of 54,371 shares — an estimated $1.1M sold.

Yakira Capital Management first reported a position in OPNT in Q4 2022 and held it in 1 quarter. The position peaked at $1.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold OPNT as of Q1 2023.

Yakira Capital Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Yakira Capital Management sold 54,371 Opiant Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $1.1M.
Yakira Capital Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Yakira Capital Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $1.1M in Q4 2022.
0 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Yakira Capital Management's 13F filing for Q1 2023, filed 12 May 2023.